UNSPSC 51282428: Ticarcillin sodium

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C15H14N2O6S2.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G8TVV6DSYG, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-, disodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as ticarcillin disodium, which bears US NIH Compound Identifier 20823.

European Medicines Agency schedules Ticarcillin disodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04857MIG. Most nations, for tariff and trade purposes, schedule ticarcillin sodium under HS 29411090. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3CCSC3)C(=O)[O-])C(=O)[O-])C.[NA+].[NA+].

UNSPSC 51282428 Ticarcillin sodium, a Commodity code, shows little relevant recent activity in state and local procurement. The two opportunities tagged under this code involve pharmaceutical procurement through state health departments and county health systems, but neither solicitation actually addresses ticarcillin sodium or related injectable antibiotics. The Illinois Department of Public Health awarded a completed piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for oral antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and Seminole County, Florida issued an IFB for Naloxone and drug deactivation systems—both unrelated to the ticarcillin sodium scope that the code nominally covers. State and local governments do procure injectable pharmaceuticals through health departments and public health agencies, but the tagged opportunities do not reflect procurement of ticarcillin sodium specifically.

The geographic footprint reflected in these records spans Illinois and Florida, with activity driven by state departments of public health and county health systems. The Illinois Department of Public Health's award to Chartwell Rx LLC was for $2.9 million over a three-year initial term plus renewals, while Seminole County's procurement (IFB 60459723LAS, due July 26, 2023) sought 1,900 units of Naloxone and 800 drug deactivation systems annually with quarterly deliveries. The mismatch between the code's scope and the actual products being solicited suggests either miscoding in the state and local procurement systems or limited use of ticarcillin sodium in current state and local health procurement. Vendors evaluating this code should assess whether ticarcillin sodium demand exists outside these tagged opportunities or confirm the code is not actively used for the products they supply.